AbCellera Biologics Inc. (ABCL): A Bull Case Theory

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc. (ABCL)'s share was trading at $2.94 as of Jan 16^th. ABCL’s trailing P/E was 19.92 according to Yahoo Finance.

[caption id="attachment_1214012" align="aligncenter" width="768"] A data scientist standing in front of a large monitor presenting a drug discovery analysis.[/caption]

AbCellera is a biotechnology company that specializes in antibody discovery using cutting-edge technologies, such as...